Titan Biotech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	215.32	248.53	248.44	216.84	303.35
Depreciation & Amortization	41.5	33.04	25.74	23.47	22.08
Other Amortization	0.2	0.27	0.27	0.22	0.12
Other Operating Activities	-20.32	2.4	-33.07	13.18	34.27
Change in Accounts Receivable	-0.95	24.5	-45.19	20.32	-138.52
Change in Inventory	-51.52	-94.02	-14.9	-78.52	-45.62
Change in Accounts Payable	18.48	-21.82	13.89	24.88	15.13
Change in Other Net Operating Assets	-1.47	18.57	16.6	-	-
Operating Cash Flow	201.23	211.46	211.78	220.41	190.82
Operating Cash Flow Growth	-4.84%	-0.15%	-3.91%	15.50%	211.98%
Capital Expenditures	-93.69	-194.85	-127.34	-63.11	-30.11
Sale of Property, Plant & Equipment	0.16	2.21	2.94	-	-
Sale (Purchase) of Intangibles	-0.47	-0.37	-0.07	-	-
Investment in Securities	-13.02	-115.97	-75.55	-27.56	-
Other Investing Activities	8.27	105.94	-7.24	-73.69	-18.54
Investing Cash Flow	-98.75	-203.04	-207.25	-164.37	-48.65
Short-Term Debt Issued	-	0.18	2.49	-	-
Long-Term Debt Issued	-	1.54	1.15	-	16.48
Total Debt Issued	-	1.72	3.64	-	16.48
Short-Term Debt Repaid	-48	-	-	-9.91	-
Long-Term Debt Repaid	-7.07	-3.81	-7.82	-9.96	-97.54
Total Debt Repaid	-55.06	-3.81	-7.82	-19.87	-97.54
Net Debt Issued (Repaid)	-55.06	-2.09	-4.18	-19.87	-81.05
Common Dividends Paid	-16.53	-14.88	-12.4	-12.4	-8.26
Other Financing Activities	-8.02	-11.7	-7.46	-8.72	-16.68
Financing Cash Flow	-79.61	-28.66	-24.03	-40.99	-105.99
Miscellaneous Cash Flow Adjustments	-	-	-	0	-
Net Cash Flow	22.88	-20.24	-19.5	15.05	36.18
Free Cash Flow	107.55	16.61	84.45	157.29	160.71
Free Cash Flow Growth	547.32%	-80.33%	-46.31%	-2.13%	162.76%
Free Cash Flow Margin	6.87%	1.01%	5.86%	12.73%	11.30%
Free Cash Flow Per Share	2.60	0.40	2.04	3.81	3.89
Cash Interest Paid	4.4	7.96	4.5	5.99	14.2
Cash Income Tax Paid	59.9	78.7	75	71.18	108.84
Levered Free Cash Flow	64.85	-46.26	28.91	107.87	163.34
Unlevered Free Cash Flow	67.61	-41.28	31.73	111.62	172.58
Change in Working Capital	-35.46	-72.77	-29.6	-33.31	-169.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.